Omni Los Angeles Hotel
Los Angeles, California


SYMPOSIUM INFORMATION

>General Information
>Faculty
>Program/Schedule
>Accreditation/CME Surveys
>Registration
>Hotel Reservations

 

Supported by:
GOOD SAMARITAN HOSPITAL
Los Angeles, CA


Affiliated With:
AMERICAN COLLEGE OF CARDIOLOGY



THIRD ANNUAL SYMPOSIUM

Contemporary Management of
Cardiovascular Disease in Women

February 9, 2019

IMPORTANT CME CREDIT NOTICE
CME Certificates will be issued digitally after Speaker and Symposium Surveys are completed. Surveys are accessible after logging in with the email address you submitted during registration.

Surveys will be accessible online the day of the symposium and for 3 weeks following. You must complete the process by March 2, 2019 in order to receive your certificate. Certificates will be available online until October 1, 2019 and are printable directly from the website.

2018 CME Surveys and Certificates - Login Required.


 

ACCREDITATION
This Live activity, 4th Annual Contemporary Management of Cardiovascular Disease in Women, with a beginning date of February 9, 2019 is being reviewed for up to TBD Prescribed credit(s) by an accrediting organization. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

COURSE DESCRIPTION
Heart disease is the leading cause of death in women in the US and accounts for more deaths each year than all of the other causes combined. In women of racial or ethnic minority the rates of death are even higher. One in three women will die of some form of heart or vascular disease. However, only one-third of women are aware of this statistic and only half would call 911 if they had symptoms of heart attack. Compared to men, women are less likely to receive standard of care of treatment for chest pain, less likely to be referred to a cardiologist, and less likely to be admitted to the hospital. It is our mission to educate healthcare providers about the risk of heart disease in women and empower them to be advocates for women's cardiovascular health.

This educational symposium will define risk factors for cardiovascular disease in women and how they differ from men, the impact of cardiovascular disease in women worldwide, and gender-specific treatments. Discussions will include pathophysiology of pregnancy related complications, the risks and benefits of hormone therapy, the benefits of biventricular therapy in women and heart failure management, and advances in management of dyslipidemia, atrial fibrillation and coronary microvascular dysfunction. State of the art therapies for structural heart disease, with an emphasis on outcomes in women, will be discussed.

The objective of this symposium is to educate healthcare providers on gender-appropriate approaches in prevention, diagnosis and treatment of women with a broad range of cardiovascular diseases.

PROGRAM OBJECTIVES
Objectives will be posting soon.

NEEDS ASSESSMENT
Heart disease is the leading cause of death in women in the US and accounts for more deaths each year than all other causes combined. In women of racial or ethnic minority the rates of death are even higher. One in three women will die of some form of heart or vascular disease. However, only one-third of women are aware of this statistic and only half would call 911 if they had symptoms of a heart attack. Compared to men, women are less likely to receive standard of care treatment for chest pain, less likely to be referred to a cardiologist, and less likely to be admitted to the hospital. It is our mission to educate healthcare providers about the risk of heart disease in women and empower them to be advocates for women's cardiovascular health. This educational symposium with define risk factors for cardiovascular disease in women and how they differ from men, the impact of cardiovascular disease in women worldwide, and gender-specific treatments.

TARGET AUDIENCE
This program has been designed to provide primary care physicians, internists, cardiologists, nurse practitioners, physician assistants, nurses, pharmacists and other healthcare providers with the necessary information to increase knowledge and awareness of cardiovascular disease in women with the goal of improving patient care.

FACULTY DISCLOSURE
It is our policy to ensure balance, independence, objectivity and scientific rigor. All persons involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. All conflicts of interest will be resolved prior to an educational activity being delivered to learners through one of the following mechanisms 1) altering the financial relationship with the commercial interest, 2) altering the individualís control over CME content about the products or services of the commercial interest, and/or 3) validating the activity content through independent peer review. All persons are also required to disclose any discussions of off label/unapproved uses of drugs or devices. Persons who refuse or fail to disclose are disqualified from participating in the CME activity. Participants will be asked to evaluate whether the speakerís outside interests reflect a possible bias in the planning or presentation of the activity. This information is used to plan future activities.